NCT00086086View on ClinicalTrials.gov

Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2003

Conditions
Congestive Heart FailureAnemia
Interventions
DRUG

Darbepoetin Alfa

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY